Lees CJ - Search Results

1

Sleeping Beauty transposon-mediated engineering of human primary T cells for therapy of CD19+ lymphoid malignancies.

Huang X, Guo H, Kang J, Choi S, Zhou TC, Tammana S, Lees CJ, Li ZZ, Milone M, Levine BL, Tolar J, June CH, Scott McIvor R, Wagner JE, Blazar BR, Zhou X. Huang X, et al. Among authors: lees cj. Mol Ther. 2008 Mar;16(3):580-9. doi: 10.1038/sj.mt.6300404. Epub 2008 Jan 29. Mol Ther. 2008. PMID: 18227839 Free PMC article.

2

Engraftment of severe combined immune deficient mice receiving allogeneic bone marrow via In utero or postnatal transfer.

Blazar BR, Taylor PA, McElmurry R, Tian L, Panoskaltsis-Mortari A, Lam S, Lees C, Waldschmidt T, Vallera DA. Blazar BR, et al. Blood. 1998 Nov 15;92(10):3949-59. Blood. 1998. PMID: 9808589 Free article.

3

Host T cells resist graft-versus-host disease mediated by donor leukocyte infusions.

Blazar BR, Lees CJ, Martin PJ, Noelle RJ, Kwon B, Murphy W, Taylor PA. Blazar BR, et al. Among authors: lees cj. J Immunol. 2000 Nov 1;165(9):4901-9. doi: 10.4049/jimmunol.165.9.4901. J Immunol. 2000. PMID: 11046015

4

Requirements for the promotion of allogeneic engraftment by anti-CD154 (anti-CD40L) monoclonal antibody under nonmyeloablative conditions.

Taylor PA, Lees CJ, Waldmann H, Noelle RJ, Blazar BR. Taylor PA, et al. Among authors: lees cj. Blood. 2001 Jul 15;98(2):467-74. doi: 10.1182/blood.v98.2.467. Blood. 2001. PMID: 11435318 Free article.

5

Allogenic fetal liver cells have a distinct competitive engraftment advantage over adult bone marrow cells when infused into fetal as compared with adult severe combined immunodeficient recipients.

Taylor PA, McElmurry RT, Lees CJ, Harrison DE, Blazar BR. Taylor PA, et al. Among authors: lees cj. Blood. 2002 Mar 1;99(5):1870-2. doi: 10.1182/blood.v99.5.1870. Blood. 2002. PMID: 11861310 Free article.

6

The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality.

Taylor PA, Lees CJ, Blazar BR. Taylor PA, et al. Among authors: lees cj. Blood. 2002 May 15;99(10):3493-9. doi: 10.1182/blood.v99.10.3493. Blood. 2002. PMID: 11986199 Free article.

7

Combined effects of calcineurin inhibitors or sirolimus with anti-CD40L mAb on alloengraftment under nonmyeloablative conditions.

Taylor PA, Lees CJ, Wilson JM, Ehrhardt MJ, Campbell MT, Noelle RJ, Blazar BR. Taylor PA, et al. Among authors: lees cj. Blood. 2002 Nov 1;100(9):3400-7. doi: 10.1182/blood-2002-03-0872. Blood. 2002. PMID: 12384443 Free article.

8

Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipients.

Blazar BR, Sharpe AH, Chen AI, Panoskaltsis-Mortari A, Lees C, Akiba H, Yagita H, Killeen N, Taylor PA. Blazar BR, et al. Blood. 2003 May 1;101(9):3741-8. doi: 10.1182/blood-2002-10-3048. Epub 2003 Jan 9. Blood. 2003. PMID: 12521997 Free article.

9

B7 expression on T cells down-regulates immune responses through CTLA-4 ligation via T-T interactions [corrections].

Taylor PA, Lees CJ, Fournier S, Allison JP, Sharpe AH, Blazar BR. Taylor PA, et al. Among authors: lees cj. J Immunol. 2004 Jan 1;172(1):34-9. doi: 10.4049/jimmunol.172.1.34. J Immunol. 2004. PMID: 14688306

10

In vivo imaging of graft-versus-host-disease in mice.

Panoskaltsis-Mortari A, Price A, Hermanson JR, Taras E, Lees C, Serody JS, Blazar BR. Panoskaltsis-Mortari A, et al. Blood. 2004 May 1;103(9):3590-8. doi: 10.1182/blood-2003-08-2827. Epub 2004 Jan 8. Blood. 2004. PMID: 14715632 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters